const mock = [];
const mock1 = '[{"startDate":"2023-10-08T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 50228018010 Gabapentin Cap 300 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 270 - Supply: 90"},{"startDate":"2023-10-05T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 31722071390 Pantoprazole Sodium EC Tab 40 MG (Base Equiv) ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 30 - Supply: 30"},{"startDate":"2023-10-02T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Basophils [#/volume] in Blood by Automated count 0.1\\n• BASOPHILS ABSOLUTE COUNT 0.1\\n• BASOPHILS RELATIVE PERCENT 0.7\\n• Basophils/100 leukocytes in Blood by Automated count 0.7\\n• Eosinophils [#/volume] in Blood by Automated count 0.0\\n• EOSINOPHILS ABSOLUTE COUNT 0.0\\n• EOSINOPHILS RELATIVE PERCENT 0.6\\n• Eosinophils/100 leukocytes in Blood by Automated count 0.6\\n• Erythrocyte distribution width [Ratio] by Automated count 17.2\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 33.2\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 32.5\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 102.2\\n• Erythrocytes [#/volume] in Blood 3.55\\n• HEMATOCRIT 36.2\\n• Hematocrit [Volume Fraction] of Blood 36.2\\n• HEMOGLOBIN 11.8\\n• Hemoglobin [Mass/volume] in Blood 11.8\\n• Leukocytes [#/volume] in Blood 6.9\\n• Lymphocytes [#/volume] in Blood by Automated count 1.4\\n• LYMPHOCYTES ABSOLUTE COUNT 1.4\\n• LYMPHOCYTES RELATIVE PERCENT 20.0\\n• Lymphocytes/100 leukocytes in Blood by Automated count 20.0\\n• MEAN CORPUSCULAR HEMOGLOBIN 33.2\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 32.5\\n• MEAN CORPUSCULAR VOLUME 102.2\\n• MEAN PLATELET VOLUME 9.2\\n• Monocytes [#/volume] in Blood by Automated count 0.7\\n• MONOCYTES ABSOLUTE COUNT 0.7\\n• MONOCYTES RELATIVE PERCENT 9.6\\n• Monocytes/100 leukocytes in Blood by Automated count 9.6\\n• Neutrophils [#/volume] in Blood by Automated count 4.8\\n• NEUTROPHILS ABSOLUTE COUNT 4.8\\n• NEUTROPHILS RELATIVE PERCENT 69.1\\n• Neutrophils/100 leukocytes in Blood by Automated count 69.1\\n• PLATELET COUNT 185\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 9.2\\n• Platelets [#/volume] in Blood by Automated count 185\\n• RED BLOOD CELL COUNT 3.55\\n• RED CELL DISTRIBUTION WIDTH 17.2\\n• WBC ADJUSTED 6.9\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 13\\n• ALBUMIN 3.0\\n• Albumin [Mass/volume] in Serum or Plasma 3.0\\n• ALKALINE PHOSPHATASE 55\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 55\\n• ALT (SGPT) 13\\n• ANION GAP 5\\n• Anion gap 3 in Serum or Plasma 5\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30\\n• AST (SGOT) 30\\n• BILIRUBIN TOTAL 0.4\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.4\\n• BLOOD UREA NITROGEN 28\\n• BUN / CREAT RATIO 14\\n• CALCIUM 8.9\\n• Calcium [Mass/volume] in Serum or Plasma 8.9\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 30.0\\n• CHLORIDE 108\\n• Chloride [Moles/volume] in Serum or Plasma 108\\n• CO2 30.0\\n• CREATININE 1.96\\n• Creatinine [Mass/volume] in Serum or Plasma 1.96\\n• EGFR CKD-EPI (2021) MALE 33\\n• Glomerular filtration rate/1.73 sq M.predicted 33\\n• Glucose [Mass/volume] in Serum or Plasma 73\\n• GLUCOSE RANDOM 73\\n• POTASSIUM 4.4\\n• Potassium [Moles/volume] in Serum or Plasma 4.4\\n• Protein [Mass/volume] in Serum or Plasma 6.2\\n• PROTEIN TOTAL 6.2\\n• SODIUM 143\\n• Sodium [Moles/volume] in Serum or Plasma 143\\n• THYROID STIMULATING HORMONE 1.611\\n• Thyrotropin [Units/volume] in Serum or Plasma 1.611\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 28\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 14"},{"startDate":"2023-10-02T05:00:00.000Z","text":"Medication(s)","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 68645059090 Clopidogrel Bisulfate Tab 75 MG (Base Equiv) ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90\\n• 00310737220 Budesonide-Formoterol Fumarate Dihyd Aerosol 80-4.5 MCG/ACT Inhalation \\nWALMART PHARMACY 10-1321 - Quantity: 10 - Supply: 30"},{"startDate":"2023-09-20T05:00:00.000Z","text":"Black Card","color":"#464646","type":"Benefit","icon":"BLACKCARD","eventDetails":"• Benefit Black Card - Walmart - Smithfield 40.62 "},{"startDate":"2023-09-13T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• NAUSEA WITH VOMITING, UNSPECIFIED R11.2  - --"},{"startDate":"2023-09-13T05:00:00.000Z","text":"Medication(s)","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 00487020103 Ipratropium-Albuterol Nebu Soln 0.5-2.5(3) MG/3ML Inhalation \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 10\\n• 53746074501 Promethazine HCl Tab 12.5 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 14 - Supply: 7"},{"startDate":"2023-09-13T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  TART, LINDSAY  - UNC PHYSICIANS NETWORK LLC - Claim - 11"},{"startDate":"2023-09-11T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• NICOTINE DEPENDENCE, CIGARETTES, UNCOMPLICATED F17.210  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• CORONARY ATHEROSCLEROSIS DUE TO CALCIFIED CORONARY LESION I25.84  - --\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• OCCLUSION AND STENOSIS OF BILATERAL CAROTID ARTERIES I65.23  - --\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• EMPHYSEMA, UNSPECIFIED J43.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• LOW BACK PAIN, UNSPECIFIED M54.50  - --\\n• OTHER SPECIFIED SOFT TISSUE DISORDERS M79.89  - --\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• REPEATED FALLS R29.6  - --"},{"startDate":"2023-09-11T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 68645052254 Sertraline HCl Tab 50 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-09-11T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• G0180 Clinical MD CERTIFICATION HHA PATIENT"},{"startDate":"2023-09-11T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Observation GIZDARSKI, VESELIN Observation - REX HOSPITAL INC - Claim - 22\\n•  WONG, JORDAN  - UNC PHYSICIANS NETWORK LLC - Claim - 11"},{"startDate":"2023-09-08T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• THROMBOCYTOPENIA, UNSPECIFIED D69.6  - Coagulation Defects and Other Specified Hematological Disorders\\n• THROMBOCYTOPENIA, UNSPECIFIED D69.6  - Coagulation Defects and Other Specified Hematological Disorders\\n• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• DEFICIENCY OF OTHER SPECIFIED B GROUP VITAMINS E53.8  - --\\n• MIXED HYPERLIPIDEMIA E78.2  - --\\n• OPIOID DEPENDENCE, UNCOMPLICATED F11.20  - Substance Use Disorder, Moderate/Severe, or Substance Use with Complications(V24);Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications(V28)\\n• OPIOID DEPENDENCE, UNCOMPLICATED F11.20  - Substance Use Disorder, Moderate/Severe, or Substance Use with Complications(V24);Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications(V28)\\n• NICOTINE DEPENDENCE, CIGARETTES, UNCOMPLICATED F17.210  - --\\n• MAJOR DEPRESSIVE DISORDER, RECURRENT, MODERATE F33.1  - Major Depressive, Bipolar, and Paranoid Disorders(V24);Major Depression, Moderate or Severe, without Psychosis(V28)\\n• MAJOR DEPRESSIVE DISORDER, RECURRENT, MODERATE F33.1  - Major Depressive, Bipolar, and Paranoid Disorders(V24);Major Depression, Moderate or Severe, without Psychosis(V28)\\n• OTHER INSOMNIA G47.09  - --\\n• OTHER CHRONIC PAIN G89.29  - --\\n• UNSPECIFIED HEARING LOSS, RIGHT EAR H91.91  - --\\n• ESSENTIAL (PRIMARY) HYPERTENSION I10  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITH OTHER FORMS OF ANGINA PECTORIS I25.118  - Angina Pectoris\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITH OTHER FORMS OF ANGINA PECTORIS I25.118  - Angina Pectoris\\n• PULMONARY HYPERTENSION, UNSPECIFIED I27.20  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• OTHER DISEASES OF PULMONARY VESSELS I28.8  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• OTHER DISEASES OF PULMONARY VESSELS I28.8  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• NONRHEUMATIC AORTIC (VALVE) STENOSIS I35.0  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.32  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.32  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• OCCLUSION AND STENOSIS OF BILATERAL CAROTID ARTERIES I65.23  - --\\n• ATHEROSCLEROSIS OF AORTA I70.0  - Vascular Disease\\n• ABDOMINAL AORTIC ANEURYSM, WITHOUT RUPTURE, UNSPECIFIED I71.40  - Vascular Disease\\n• ABDOMINAL AORTIC ANEURYSM, WITHOUT RUPTURE, UNSPECIFIED I71.40  - Vascular Disease\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• EMBOLISM AND THROMBOSIS OF ILIAC ARTERY I74.5  - Vascular Disease with Complications(V24,V28)\\n• EMBOLISM AND THROMBOSIS OF ILIAC ARTERY I74.5  - Vascular Disease with Complications(V24,V28)\\n• CHRONIC RHINITIS J31.0  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PAIN IN LEFT KNEE M25.562  - --\\n• LUMBAGO WITH SCIATICA, RIGHT SIDE M54.41  - --\\n• LUMBAGO WITH SCIATICA, LEFT SIDE M54.42  - --\\n• LUMBAGO WITH SCIATICA, LEFT SIDE M54.42  - --\\n• OTHER SPECIFIED DISORDERS OF BONE DENSITY AND STRUCTURE, MULTIPLE SITES M85.89  - --\\n• CHRONIC KIDNEY DISEASE, STAGE 4 (SEVERE) N18.4  - Chronic Kidney Disease, Severe (Stage 4)(V24,V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 4 (SEVERE) N18.4  - Chronic Kidney Disease, Severe (Stage 4)(V24,V28)\\n• PROTEINURIA, UNSPECIFIED R80.9  - --\\n• ENCOUNTER FOR GENERAL ADULT MEDICAL EXAMINATION WITHOUT ABNORMAL FINDINGS Z00.00  - --\\n• ENCOUNTER FOR OTHER GENERAL EXAMINATION Z00.8  - --\\n• ENCOUNTER FOR FOLLOW-UP EXAMINATION AFTER COMPLETED TREATMENT FOR CONDITIONS OTHER THAN MALIGNANT NE Z09  - --\\n• ENCOUNTER FOR IMMUNIZATION Z23  - --\\n• ENCOUNTER FOR IMMUNIZATION Z23  - --\\n• OTHER SPECIFIED COUNSELING Z71.89  - --\\n• HISTORY OF FALLING Z91.81  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-09-08T05:00:00.000Z","text":"HCC","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders"},{"startDate":"2023-09-08T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 1125F Clinical AMNT PAIN NOTED PAIN PRSNT\\n• 90686 Claim IIV4 VACC NO PRSV 0.5 ML IM\\n• 3078F Clinical DIAST BP <80 MM HG\\n• G0008 Claim ADMIN INFLUENZA VIRUS VAC\\n• 1160F Clinical RVW MEDS BY RX/DR IN RCRD\\n• 1158F Clinical ADVNC CARE PLAN TLK DOCD\\n• 1220F Clinical PT SCREENED FOR DEPRESSION\\n• 90686 Clinical IIV4 VACC NO PRSV 0.5 ML IM\\n• 1159F Clinical MED LIST DOCD IN RCRD\\n• 1111F Clinical DSCHRG MED/CURRENT MED MERGE\\n• 3288F Clinical FALL RISK ASSESSMENT DOCD\\n• 3077F Clinical SYST BP >/= 140 MM HG\\n• 1170F Clinical FXNL STATUS ASSESSED\\n• 3008F Clinical BODY MASS INDEX DOCD\\n• 1157F Clinical ADVNC CARE PLAN IN RCRD\\n• G0008 Clinical ADMIN INFLUENZA VIRUS VAC\\n• 3720F Clinical COGNIT IMPAIRMENT ASSESSED"},{"startDate":"2023-09-08T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  WILLIAMS, MARY  - ALIGNMENT HEALTHCARE MEDICAL ASSOCIATES PC - Claim - 12"},{"startDate":"2023-09-08T05:00:00.000Z","text":"Clinical Program","type":"ClinicalProgram","eventDetails":"• CareAnywhere \\nEnrollment date: 09/08/2023 \\nEligibility date: 06/08/2023"},{"startDate":"2023-09-07T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• BASAL CELL CARCINOMA OF SKIN OF OTHER PARTS OF FACE C44.319  - --\\n• UNSPECIFIED PERICHONDRITIS OF LEFT EXTERNAL EAR H61.002  - --"},{"startDate":"2023-09-07T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 29300035501 Tramadol HCl Tab 50 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 120 - Supply: 30"},{"startDate":"2023-09-07T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  GREENSBORO PATHOLOGY, LLC  - GREENSBORO PATHOLOGY LLC - Claim - 81"},{"startDate":"2023-09-06T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE CHRONIC KIDNEY DISEASE WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIF I12.9  - --\\n• CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.32  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)"},{"startDate":"2023-09-06T05:00:00.000Z","text":"HCC(s)","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Parkinson and Other Degenerative Disease of Basal Gangli\\n• Chronic Condition Hemiplegia/Hemiparesis"},{"startDate":"2023-09-06T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 64980056210 Furosemide Tab 20 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 180 - Supply: 90"},{"startDate":"2023-09-06T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  RAASCH, ERIC  - NORTH CAROLINA NEPHROLOGY PA - Claim - 11"},{"startDate":"2023-09-05T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• COUGH, UNSPECIFIED R05.9  - --"},{"startDate":"2023-09-05T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 94060 Clinical EVALUATION OF WHEEZING"},{"startDate":"2023-09-05T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Observation HALL, WILLIAM Observation - REX HOSPITAL INC - Claim - 22\\n•    -  - Clinical - "},{"startDate":"2023-09-02T05:00:00.000Z","text":"Diagnosis","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)"},{"startDate":"2023-09-02T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  JOHNSTON HOME CARE AND HOSPICE  - JOHNSTON HEALTH SERVICES CORPORATION - Claim - 12"},{"startDate":"2023-09-01T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)"},{"startDate":"2023-09-01T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• G0152 Auth HHCP-SERV OF OT,EA 15 MIN\\n• G0155 Auth HHCP-SVS OF CSW,EA 15 MIN\\n• G0156 Auth HHCP-SVS OF AIDE,EA 15 MIN"},{"startDate":"2023-08-31T05:00:00.000Z","text":"Allergy","color":"#33B5E5","type":"Allergy","icon":"RX","eventDetails":"• OXYCODONE-ACETAMINOPHEN 12560 OXYCODONE-ACETAMINOPHEN"},{"startDate":"2023-08-31T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• NICOTINE DEPENDENCE, CIGARETTES, UNCOMPLICATED F17.210  - --\\n• OTHER CHRONIC PAIN G89.29  - --\\n• ESSENTIAL (PRIMARY) HYPERTENSION I10  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• VARICOSE VEINS OF LEFT LOWER EXTREMITY WITH OTHER COMPLICATIONS I83.892  - --\\n• HYPOTENSION, UNSPECIFIED I95.9  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• LOW BACK PAIN, UNSPECIFIED M54.50  - --\\n• SHORTNESS OF BREATH R06.02  - --\\n• SHORTNESS OF BREATH R06.02  - --\\n• SHORTNESS OF BREATH R06.02  - --\\n• SHORTNESS OF BREATH R06.02  - --\\n• WEAKNESS R53.1  - --\\n• WEAKNESS R53.1  - --\\n• EDEMA, UNSPECIFIED R60.9  - --\\n• CONTACT WITH AND (SUSPECTED) EXPOSURE TO COVID-19 Z20.822  - --\\n• CONTACT WITH AND (SUSPECTED) EXPOSURE TO COVID-19 Z20.822  - --\\n• LONG TERM (CURRENT) USE OF ANTITHROMBOTICS/ANTIPLATELETS Z79.02  - --\\n• LONG TERM (CURRENT) USE OF ASPIRIN Z79.82  - --\\n• HORMONE REPLACEMENT THERAPY Z79.890  - --\\n• OTHER LONG TERM (CURRENT) DRUG THERAPY Z79.899  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-31T05:00:00.000Z","text":"HCC","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Cardio-Respiratory Failure and Shock"},{"startDate":"2023-08-31T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• INFLUENZA A NEGATIVE\\n• INFLUENZA B NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• RSV NEGATIVE\\n• SARS coronavirus 2 RNA NEGATIVE\\n• SARS-COV-2 PCR NEGATIVE\\n• Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 8746.8\\n• PRO-BNP 8746.8\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21\\n• ALBUMIN 2.2\\n• Albumin [Mass/volume] in Serum or Plasma 2.2\\n• ALKALINE PHOSPHATASE 46\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 46\\n• ALT (SGPT) 21\\n• ANION GAP 3\\n• Anion gap 3 in Serum or Plasma 3\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34\\n• AST (SGOT) 34\\n• BILIRUBIN TOTAL 0.3\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.3\\n• BLOOD UREA NITROGEN 60\\n• BUN / CREAT RATIO 24\\n• CALCIUM 8.3\\n• Calcium [Mass/volume] in Serum or Plasma 8.3\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.3\\n• CHLORIDE 113\\n• Chloride [Moles/volume] in Serum or Plasma 113\\n• CO2 28.3\\n• CREATININE 2.52\\n• Creatinine [Mass/volume] in Serum or Plasma 2.52\\n• EGFR CKD-EPI (2021) MALE 24\\n• Glomerular filtration rate/1.73 sq M.predicted 24\\n• Glucose [Mass/volume] in Serum or Plasma 94\\n• GLUCOSE RANDOM 94\\n• POTASSIUM 5.4\\n• Potassium [Moles/volume] in Serum or Plasma 5.4\\n• Protein [Mass/volume] in Serum or Plasma 5.0\\n• PROTEIN TOTAL 5.0\\n• SODIUM 144\\n• Sodium [Moles/volume] in Serum or Plasma 144\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 60\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 24\\n• INR 1.01\\n• INR in Platelet poor plasma by Coagulation assay 1.01\\n• Prothrombin time (PT) 11.7\\n• PROTIME 11.7\\n• Basophils [#/volume] in Blood by Automated count 0.0\\n• BASOPHILS ABSOLUTE COUNT 0.0\\n• BASOPHILS RELATIVE PERCENT 0.2\\n• Basophils/100 leukocytes in Blood by Automated count 0.2\\n• Eosinophils [#/volume] in Blood by Automated count 0.1\\n• EOSINOPHILS ABSOLUTE COUNT 0.1\\n• EOSINOPHILS RELATIVE PERCENT 0.6\\n• Eosinophils/100 leukocytes in Blood by Automated count 0.6\\n• Erythrocyte distribution width [Ratio] by Automated count 16.5\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 34.1\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.9\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 100.4\\n• Erythrocytes [#/volume] in Blood 2.32\\n• HEMATOCRIT 23.3\\n• Hematocrit [Volume Fraction] of Blood 23.3\\n• HEMOGLOBIN 7.9\\n• Hemoglobin [Mass/volume] in Blood 7.9\\n• Leukocytes [#/volume] in Blood 8.5\\n• Lymphocytes [#/volume] in Blood by Automated count 1.7\\n• LYMPHOCYTES ABSOLUTE COUNT 1.7\\n• LYMPHOCYTES RELATIVE PERCENT 20.4\\n• Lymphocytes/100 leukocytes in Blood by Automated count 20.4\\n• MEAN CORPUSCULAR HEMOGLOBIN 34.1\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.9\\n• MEAN CORPUSCULAR VOLUME 100.4\\n• MEAN PLATELET VOLUME 12.0\\n• Monocytes [#/volume] in Blood by Automated count 0.9\\n• MONOCYTES ABSOLUTE COUNT 0.9\\n• MONOCYTES RELATIVE PERCENT 10.9\\n• Monocytes/100 leukocytes in Blood by Automated count 10.9\\n• Neutrophils [#/volume] in Blood by Automated count 5.7\\n• NEUTROPHILS ABSOLUTE COUNT 5.7\\n• NEUTROPHILS RELATIVE PERCENT 67.1\\n• Neutrophils/100 leukocytes in Blood by Automated count 67.1\\n• PLATELET COUNT 143\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 12.0\\n• Platelets [#/volume] in Blood by Automated count 143\\n• RED BLOOD CELL COUNT 2.32\\n• RED CELL DISTRIBUTION WIDTH 16.5\\n• WBC ADJUSTED 8.5"},{"startDate":"2023-08-31T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Observation CARTER, CRAIG Observation - CRAIG S CARTER MD FACS PA - Claim - 22\\n• Emergency Room COASTAL PLAINS PATHOLOGY PA Emergency Room - COASTAL PLAINS PATHOLOGY PA - Claim - 23\\n•  JOHNSTON COUNTY EMS  - JOHNSTON COUNTY - Claim - 41\\n• Emergency Room JOHNSTON HEALTH SERVICES CORPORATION Emergency Room - JOHNSTON HEALTH SERVICES CORPORATION - Claim - 23\\n• Emergency Room WAKE EMERGENCY PHYSICIANS PA Emergency Room - WAKE EMERGENCY PHYSICIANS PA - Claim - 23\\n• Emergency Room WAKE RADIOLOGY CONSULTANTS PA Emergency Room - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 23"},{"startDate":"2023-08-30T05:00:00.000Z","text":"Diagnosis","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• OTHER SPECIFIED SOFT TISSUE DISORDERS M79.89  - --"},{"startDate":"2023-08-30T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 93971 Auth EXTREMITY STUDY"},{"startDate":"2023-08-29T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• OTHER SPECIFIED SOFT TISSUE DISORDERS M79.89  - --\\n• OTHER SPECIFIED SOFT TISSUE DISORDERS M79.89  - --\\n• LOCALIZED SWELLING, MASS AND LUMP, LEFT UPPER LIMB R22.32  - --"},{"startDate":"2023-08-29T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Basophils [#/volume] in Blood by Automated count 0.0\\n• BASOPHILS ABSOLUTE COUNT 0.0\\n• BASOPHILS RELATIVE PERCENT 0.6\\n• Basophils/100 leukocytes in Blood by Automated count 0.6\\n• Eosinophils [#/volume] in Blood by Automated count 0.1\\n• EOSINOPHILS ABSOLUTE COUNT 0.1\\n• EOSINOPHILS RELATIVE PERCENT 1.2\\n• Eosinophils/100 leukocytes in Blood by Automated count 1.2\\n• Erythrocyte distribution width [Ratio] by Automated count 16.3\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 33.2\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.0\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 100.7\\n• Erythrocytes [#/volume] in Blood 2.63\\n• HEMATOCRIT 26.4\\n• Hematocrit [Volume Fraction] of Blood 26.4\\n• HEMOGLOBIN 8.7\\n• Hemoglobin [Mass/volume] in Blood 8.7\\n• Leukocytes [#/volume] in Blood 6.9\\n• Lymphocytes [#/volume] in Blood by Automated count 1.4\\n• LYMPHOCYTES ABSOLUTE COUNT 1.4\\n• LYMPHOCYTES RELATIVE PERCENT 20.8\\n• Lymphocytes/100 leukocytes in Blood by Automated count 20.8\\n• MEAN CORPUSCULAR HEMOGLOBIN 33.2\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.0\\n• MEAN CORPUSCULAR VOLUME 100.7\\n• MEAN PLATELET VOLUME 10.6\\n• Monocytes [#/volume] in Blood by Automated count 0.8\\n• MONOCYTES ABSOLUTE COUNT 0.8\\n• MONOCYTES RELATIVE PERCENT 10.9\\n• Monocytes/100 leukocytes in Blood by Automated count 10.9\\n• Neutrophils [#/volume] in Blood by Automated count 4.6\\n• NEUTROPHILS ABSOLUTE COUNT 4.6\\n• NEUTROPHILS RELATIVE PERCENT 66.5\\n• Neutrophils/100 leukocytes in Blood by Automated count 66.5\\n• PLATELET COUNT 115\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 10.6\\n• Platelets [#/volume] in Blood by Automated count 115\\n• RED BLOOD CELL COUNT 2.63\\n• RED CELL DISTRIBUTION WIDTH 16.3\\n• WBC ADJUSTED 6.9\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22\\n• ALBUMIN 2.5\\n• Albumin [Mass/volume] in Serum or Plasma 2.5\\n• ALKALINE PHOSPHATASE 46\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 46\\n• ALT (SGPT) 22\\n• ANION GAP 1\\n• Anion gap 3 in Serum or Plasma 1\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 39\\n• AST (SGOT) 39\\n• BILIRUBIN TOTAL 0.4\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.4\\n• BLOOD UREA NITROGEN 61\\n• BUN / CREAT RATIO 30\\n• CALCIUM 8.5\\n• Calcium [Mass/volume] in Serum or Plasma 8.5\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 30.0\\n• CHLORIDE 109\\n• Chloride [Moles/volume] in Serum or Plasma 109\\n• CO2 30.0\\n• CREATININE 2.03\\n• Creatinine [Mass/volume] in Serum or Plasma 2.03\\n• EGFR CKD-EPI (2021) MALE 32\\n• Glomerular filtration rate/1.73 sq M.predicted 32\\n• Glucose [Mass/volume] in Serum or Plasma 70\\n• GLUCOSE RANDOM 70\\n• POTASSIUM 5.6\\n• Potassium [Moles/volume] in Serum or Plasma 5.6\\n• Protein [Mass/volume] in Serum or Plasma 5.6\\n• PROTEIN TOTAL 5.6\\n• SODIUM 140\\n• Sodium [Moles/volume] in Serum or Plasma 140\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 61\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 30"},{"startDate":"2023-08-29T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 00487020103 Ipratropium-Albuterol Nebu Soln 0.5-2.5(3) MG/3ML Inhalation \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 10"},{"startDate":"2023-08-29T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• G0299 Auth HHS/HOSPICE OF RN EA 15 MIN\\n• G0151 Auth HHCP-SERV OF PT,EA 15 MIN\\n• G0157 Auth HHC PT ASSISTANT EA 15\\n• G0300 Auth HHS/HOSPICE OF LPN EA 15 MIN"},{"startDate":"2023-08-29T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  REX HEALTHCARE OF WAKEFIELD- LABORATORY  - REX HOSPITAL INC - Claim - 81\\n•  WONG, JORDAN  - UNC PHYSICIANS NETWORK LLC - Claim - 11"},{"startDate":"2023-08-27T05:00:00.000Z","text":"Black Card","color":"#464646","type":"Benefit","icon":"BLACKCARD","eventDetails":"• Benefit Black Card - WALGREENS STORE - NORTH MYRTLE -110.31 "},{"startDate":"2023-08-26T05:00:00.000Z","text":"HCC","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Chronic Obstructive Pulmonary Disease"},{"startDate":"2023-08-25T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• MIXED HYPERLIPIDEMIA E78.2  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CEREBRAL INFARCTION, UNSPECIFIED I63.9  - Ischemic or Unspecified Stroke(V24,V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 3 UNSPECIFIE N18.30  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3, Except 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-25T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• POTASSIUM 4.7\\n• Potassium [Moles/volume] in Serum or Plasma 4.7\\n• ANION GAP 3\\n• Anion gap 3 in Serum or Plasma 3\\n• BLOOD UREA NITROGEN 96\\n• BUN / CREAT RATIO 47\\n• CALCIUM 8.2\\n• Calcium [Mass/volume] in Serum or Plasma 8.2\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.9\\n• CHLORIDE 112\\n• Chloride [Moles/volume] in Serum or Plasma 112\\n• CO2 28.9\\n• CREATININE 2.05\\n• Creatinine [Mass/volume] in Serum or Plasma 2.05\\n• EGFR CKD-EPI (2021) MALE 31\\n• Glomerular filtration rate/1.73 sq M.predicted 31\\n• Glucose [Mass/volume] in Serum or Plasma 95\\n• GLUCOSE RANDOM 95\\n• MAGNESIUM 2.1\\n• Magnesium [Mass/volume] in Serum or Plasma 2.1\\n• POTASSIUM 5.2\\n• Potassium [Moles/volume] in Serum or Plasma 5.2\\n• SODIUM 144\\n• Sodium [Moles/volume] in Serum or Plasma 144\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 96\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 47\\n• Erythrocyte distribution width [Ratio] by Automated count 16.4\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 32.4\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 32.4\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 100.0\\n• Erythrocytes [#/volume] in Blood 2.96\\n• HEMATOCRIT 29.6\\n• Hematocrit [Volume Fraction] of Blood 29.6\\n• HEMOGLOBIN 9.6\\n• Hemoglobin [Mass/volume] in Blood 9.6\\n• Leukocytes [#/volume] in Blood 4.8\\n• MEAN CORPUSCULAR HEMOGLOBIN 32.4\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 32.4\\n• MEAN CORPUSCULAR VOLUME 100.0\\n• MEAN PLATELET VOLUME 11.3\\n• PLATELET COUNT 173\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.3\\n• Platelets [#/volume] in Blood by Automated count 173\\n• RED BLOOD CELL COUNT 2.96\\n• RED CELL DISTRIBUTION WIDTH 16.4\\n• WBC ADJUSTED 4.8"},{"startDate":"2023-08-25T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• G0151 Auth HHCP-SERV OF PT,EA 15 MIN\\n• G0299 Auth HHS/HOSPICE OF RN EA 15 MIN"},{"startDate":"2023-08-25T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient FRENCH, JOHN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient GIZDARSKI, VESELIN Inpatient - REX HOSPITAL INC - Claim - 21"},{"startDate":"2023-08-24T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• HYPOGLYCEMIA, UNSPECIFIED E16.2  - --\\n• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• CEREBROVASCULAR DISEASE, UNSPECIFIED I67.9  - --\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --"},{"startDate":"2023-08-24T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• POTASSIUM 4.9\\n• Potassium [Moles/volume] in Serum or Plasma 4.9\\n• Glucose [Mass/volume] in Blood by Automated test strip 142\\n• POC GLUCOSE 142\\n• Glucose [Mass/volume] in Blood by Automated test strip 110\\n• POC GLUCOSE 110\\n• Glucose [Mass/volume] in Blood by Automated test strip 83\\n• POC GLUCOSE 83\\n• LACTATE DEHYDROGENASE 223\\n• Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction 223\\n• Glucose [Mass/volume] in Blood by Automated test strip 124\\n• POC GLUCOSE 124\\n• ANION GAP 3\\n• Anion gap 3 in Serum or Plasma 3\\n• BLOOD UREA NITROGEN 110\\n• BUN / CREAT RATIO 47\\n• CALCIUM 8.1\\n• Calcium [Mass/volume] in Serum or Plasma 8.1\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.6\\n• CHLORIDE 111\\n• Chloride [Moles/volume] in Serum or Plasma 111\\n• CO2 28.6\\n• CREATININE 2.35\\n• Creatinine [Mass/volume] in Serum or Plasma 2.35\\n• EGFR CKD-EPI (2021) MALE 27\\n• Glomerular filtration rate/1.73 sq M.predicted 27\\n• Glucose [Mass/volume] in Serum or Plasma 69\\n• GLUCOSE RANDOM 69\\n• MAGNESIUM 2.1\\n• Magnesium [Mass/volume] in Serum or Plasma 2.1\\n• POTASSIUM 5.3\\n• Potassium [Moles/volume] in Serum or Plasma 5.3\\n• SODIUM 143\\n• Sodium [Moles/volume] in Serum or Plasma 143\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 110\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 47\\n• Erythrocyte distribution width [Ratio] by Automated count 16.2\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 32.6\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.1\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 98.6\\n• Erythrocytes [#/volume] in Blood 2.82\\n• HEMATOCRIT 27.8\\n• Hematocrit [Volume Fraction] of Blood 27.8\\n• HEMOGLOBIN 9.2\\n• Hemoglobin [Mass/volume] in Blood 9.2\\n• Leukocytes [#/volume] in Blood 5.2\\n• MEAN CORPUSCULAR HEMOGLOBIN 32.6\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.1\\n• MEAN CORPUSCULAR VOLUME 98.6\\n• MEAN PLATELET VOLUME 10.8\\n• PLATELET COUNT 166\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 10.8\\n• Platelets [#/volume] in Blood by Automated count 166\\n• RED BLOOD CELL COUNT 2.82\\n• RED CELL DISTRIBUTION WIDTH 16.2\\n• WBC ADJUSTED 5.2"},{"startDate":"2023-08-24T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 68645058054 Amlodipine Besylate Tab 10 MG (Base Equivalent) ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-08-24T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient ATKESON, BENJAMIN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient GIZDARSKI, VESELIN Inpatient - REX HOSPITAL INC - Claim - 21"},{"startDate":"2023-08-23T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA, UNSPECIFIED D64.9  - --\\n• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE CHRONIC KIDNEY DISEASE WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIF I12.9  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CEREBRAL INFARCTION, UNSPECIFIED I63.9  - Ischemic or Unspecified Stroke(V24,V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 UNSPECIFIE N18.30  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3, Except 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --\\n• UNSPECIFIED KIDNEY FAILURE N19  - --\\n• RETENTION OF URINE, UNSPECIFIED R33.9  - --"},{"startDate":"2023-08-23T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• BACTERIA NONE SEEN\\n• Bacteria NONE SEEN\\n• BILIRUBIN UA NEGATIVE\\n• Bilirubin.total [Presence] in Urine by Test strip NEGATIVE\\n• BLOOD UA NEGATIVE\\n• CLARITY CLEAR\\n• COLOR LIGHT YELLOW\\n• Color of Urine LIGHT YELLOW\\n• Erythrocytes [#/area] in Urine sediment by Microscopy high power field 1\\n• Glucose [Mass/volume] in Urine by Test strip NEGATIVE\\n• GLUCOSE UA NEGATIVE\\n• Hemoglobin [Presence] in Urine by Test strip NEGATIVE\\n• HYPHAL YEAST NONE SEEN\\n• Ketones [Mass/volume] in Urine by Test strip NEGATIVE\\n• KETONES UA NEGATIVE\\n• Leukocyte esterase [Presence] in Urine by Test strip NEGATIVE\\n• LEUKOCYTE ESTERASE UA NEGATIVE\\n• Leukocytes [#/area] in Urine sediment by Microscopy high power field 1\\n• MUCUS RARE\\n• Mucus RARE\\n• Nitrite [Presence] in Urine by Test strip NEGATIVE\\n• NITRITE UA NEGATIVE\\n• pH of Urine by Test strip 5.5\\n• PH UA 5.5\\n• Protein [Mass/volume] in Urine by Test strip 2+\\n• PROTEIN UA 2+\\n• RBC UA 1\\n• Specific gravity of Urine 1.016\\n• SPECIFIC GRAVITY UA 1.016\\n• Turbidity [Presence] of Urine Qualitative CLEAR\\n• WBC UA 1\\n• YEAST NONE SEEN\\n• Yeast NONE SEEN\\n• Yeast NONE SEEN\\n• ANION GAP 11\\n• Anion gap 3 in Serum or Plasma 11\\n• BLOOD UREA NITROGEN 121\\n• BUN / CREAT RATIO 44\\n• CALCIUM 8.7\\n• Calcium [Mass/volume] in Serum or Plasma 8.7\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 26.5\\n• CHLORIDE 105\\n• Chloride [Moles/volume] in Serum or Plasma 105\\n• CO2 26.5\\n• CREATININE 2.77\\n• Creatinine [Mass/volume] in Serum or Plasma 2.77\\n• EGFR CKD-EPI (2021) MALE 22\\n• Glomerular filtration rate/1.73 sq M.predicted 22\\n• Glucose [Mass/volume] in Serum or Plasma 111\\n• GLUCOSE RANDOM 111\\n• MAGNESIUM 2.1\\n• Magnesium [Mass/volume] in Serum or Plasma 2.1\\n• POTASSIUM 4.4\\n• Potassium [Moles/volume] in Serum or Plasma 4.4\\n• SODIUM 142\\n• Sodium [Moles/volume] in Serum or Plasma 142\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 121\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 44\\n• Erythrocyte distribution width [Ratio] by Automated count 16.0\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 33.1\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.3\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 99.4\\n• Erythrocytes [#/volume] in Blood 3.20\\n• HEMATOCRIT 31.8\\n• Hematocrit [Volume Fraction] of Blood 31.8\\n• HEMOGLOBIN 10.6\\n• Hemoglobin [Mass/volume] in Blood 10.6\\n• Leukocytes [#/volume] in Blood 9.7\\n• MEAN CORPUSCULAR HEMOGLOBIN 33.1\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.3\\n• MEAN CORPUSCULAR VOLUME 99.4\\n• MEAN PLATELET VOLUME 11.9\\n• PLATELET COUNT 197\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.9\\n• Platelets [#/volume] in Blood by Automated count 197\\n• RED BLOOD CELL COUNT 3.20\\n• RED CELL DISTRIBUTION WIDTH 16.0\\n• WBC ADJUSTED 9.7"},{"startDate":"2023-08-23T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient AKHTAR, MATEEN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient GIZDARSKI, VESELIN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient SONAWANE, SAMSHER Inpatient - NORTH CAROLINA NEPHROLOGY PA - Claim - 21\\n• Inpatient WAKE RADIOLOGY CONSULTANTS PA Inpatient - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 21"},{"startDate":"2023-08-22T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• CEREBRAL INFARCTION, UNSPECIFIED I63.9  - Ischemic or Unspecified Stroke(V24,V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --\\n• REPEATED FALLS R29.6  - --\\n• RETENTION OF URINE, UNSPECIFIED R33.9  - --\\n• ENCOUNTER FOR FOLLOW-UP EXAMINATION AFTER COMPLETED TREATMENT FOR CONDITIONS OTHER THAN MALIGNANT NE Z09  - --\\n• LONG TERM (CURRENT) USE OF ANTIBIOTICS Z79.2  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-22T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• ANION GAP 8\\n• Anion gap 3 in Serum or Plasma 8\\n• BLOOD UREA NITROGEN 114\\n• BUN / CREAT RATIO 46\\n• CALCIUM 8.7\\n• Calcium [Mass/volume] in Serum or Plasma 8.7\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 29.3\\n• CHLORIDE 106\\n• Chloride [Moles/volume] in Serum or Plasma 106\\n• CO2 29.3\\n• CREATININE 2.48\\n• Creatinine [Mass/volume] in Serum or Plasma 2.48\\n• EGFR CKD-EPI (2021) MALE 25\\n• Glomerular filtration rate/1.73 sq M.predicted 25\\n• Glucose [Mass/volume] in Serum or Plasma 151\\n• GLUCOSE RANDOM 151\\n• MAGNESIUM 2.1\\n• Magnesium [Mass/volume] in Serum or Plasma 2.1\\n• POTASSIUM 5.0\\n• Potassium [Moles/volume] in Serum or Plasma 5.0\\n• SODIUM 143\\n• Sodium [Moles/volume] in Serum or Plasma 143\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 114\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 46\\n• Erythrocyte distribution width [Ratio] by Automated count 16.1\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 33.7\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.5\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 100.3\\n• Erythrocytes [#/volume] in Blood 3.15\\n• HEMATOCRIT 31.6\\n• Hematocrit [Volume Fraction] of Blood 31.6\\n• HEMOGLOBIN 10.6\\n• Hemoglobin [Mass/volume] in Blood 10.6\\n• Leukocytes [#/volume] in Blood 9.2\\n• MEAN CORPUSCULAR HEMOGLOBIN 33.7\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.5\\n• MEAN CORPUSCULAR VOLUME 100.3\\n• MEAN PLATELET VOLUME 11.5\\n• PLATELET COUNT 186\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.5\\n• Platelets [#/volume] in Blood by Automated count 186\\n• RED BLOOD CELL COUNT 3.15\\n• RED CELL DISTRIBUTION WIDTH 16.1\\n• WBC ADJUSTED 9.2"},{"startDate":"2023-08-22T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient ATKESON, BENJAMIN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient GIZDARSKI, VESELIN Inpatient - REX HOSPITAL INC - Claim - 21"},{"startDate":"2023-08-21T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --\\n• REPEATED FALLS R29.6  - --\\n• LONG TERM (CURRENT) USE OF ANTIBIOTICS Z79.2  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-21T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 8949.7\\n• PRO-BNP 8949.7\\n• ANION GAP 10\\n• Anion gap 3 in Serum or Plasma 10\\n• BLOOD UREA NITROGEN 101\\n• BUN / CREAT RATIO 40\\n• CALCIUM 9.2\\n• Calcium [Mass/volume] in Serum or Plasma 9.2\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.1\\n• CHLORIDE 105\\n• Chloride [Moles/volume] in Serum or Plasma 105\\n• CO2 28.1\\n• CREATININE 2.50\\n• Creatinine [Mass/volume] in Serum or Plasma 2.50\\n• EGFR CKD-EPI (2021) MALE 25\\n• Glomerular filtration rate/1.73 sq M.predicted 25\\n• Glucose [Mass/volume] in Serum or Plasma 97\\n• GLUCOSE RANDOM 97\\n• MAGNESIUM 2.1\\n• Magnesium [Mass/volume] in Serum or Plasma 2.1\\n• POTASSIUM 4.4\\n• Potassium [Moles/volume] in Serum or Plasma 4.4\\n• SODIUM 143\\n• Sodium [Moles/volume] in Serum or Plasma 143\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 101\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 40\\n• Erythrocyte distribution width [Ratio] by Automated count 15.9\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 32.7\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 33.1\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 98.8\\n• Erythrocytes [#/volume] in Blood 3.42\\n• HEMATOCRIT 33.8\\n• Hematocrit [Volume Fraction] of Blood 33.8\\n• HEMOGLOBIN 11.2\\n• Hemoglobin [Mass/volume] in Blood 11.2\\n• Leukocytes [#/volume] in Blood 12.8\\n• MEAN CORPUSCULAR HEMOGLOBIN 32.7\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 33.1\\n• MEAN CORPUSCULAR VOLUME 98.8\\n• MEAN PLATELET VOLUME 11.8\\n• PLATELET COUNT 208\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.8\\n• Platelets [#/volume] in Blood by Automated count 208\\n• RED BLOOD CELL COUNT 3.42\\n• RED CELL DISTRIBUTION WIDTH 15.9\\n• WBC ADJUSTED 12.8"},{"startDate":"2023-08-21T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient FRENCH, JOHN Inpatient - REX HOSPITAL INC - Claim - 21"},{"startDate":"2023-08-20T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• OTHER PERICARDIAL EFFUSION (NONINFLAMMATORY) I31.39  - --\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• PNEUMONIA, UNSPECIFIED ORGANISM J18.9  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ATELECTASIS J98.11  - --\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• REPEATED FALLS R29.6  - --\\n• REPEATED FALLS R29.6  - --\\n• LONG TERM (CURRENT) USE OF ANTIBIOTICS Z79.2  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-20T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• ANION GAP 11\\n• Anion gap 3 in Serum or Plasma 11\\n• BLOOD UREA NITROGEN 87\\n• BUN / CREAT RATIO 34\\n• CALCIUM 9.0\\n• Calcium [Mass/volume] in Serum or Plasma 9.0\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 28.2\\n• CHLORIDE 102\\n• Chloride [Moles/volume] in Serum or Plasma 102\\n• CO2 28.2\\n• CREATININE 2.57\\n• Creatinine [Mass/volume] in Serum or Plasma 2.57\\n• EGFR CKD-EPI (2021) MALE 24\\n• Glomerular filtration rate/1.73 sq M.predicted 24\\n• Glucose [Mass/volume] in Serum or Plasma 185\\n• GLUCOSE RANDOM 185\\n• MAGNESIUM 2.0\\n• Magnesium [Mass/volume] in Serum or Plasma 2.0\\n• POTASSIUM 3.7\\n• Potassium [Moles/volume] in Serum or Plasma 3.7\\n• SODIUM 141\\n• Sodium [Moles/volume] in Serum or Plasma 141\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 87\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 34"},{"startDate":"2023-08-20T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient SINGH, SHANTANU Inpatient - HENDERSON PULMONARY AND SLEEP MEDICINE PLLC - Claim - 21\\n• Inpatient SINGH, SHANTANU Inpatient - HENDERSON PULMONARY AND SLEEP MEDICINE PLLC - Claim - 21\\n• Inpatient WAKE RADIOLOGY CONSULTANTS PA Inpatient - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 21\\n• Inpatient WAKE RADIOLOGY CONSULTANTS PA Inpatient - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 21"},{"startDate":"2023-08-19T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• OTHER PERICARDIAL EFFUSION (NONINFLAMMATORY) I31.39  - --\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ATELECTASIS J98.11  - --\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• HYPOXEMIA R09.02  - --\\n• OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD R91.8  - --"},{"startDate":"2023-08-19T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• ANION GAP 12\\n• Anion gap 3 in Serum or Plasma 12\\n• BLOOD UREA NITROGEN 56\\n• BUN / CREAT RATIO 22\\n• CALCIUM 8.8\\n• Calcium [Mass/volume] in Serum or Plasma 8.8\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 24.6\\n• CHLORIDE 107\\n• Chloride [Moles/volume] in Serum or Plasma 107\\n• CO2 24.6\\n• CREATININE 2.58\\n• Creatinine [Mass/volume] in Serum or Plasma 2.58\\n• EGFR CKD-EPI (2021) MALE 24\\n• Glomerular filtration rate/1.73 sq M.predicted 24\\n• Glucose [Mass/volume] in Serum or Plasma 129\\n• GLUCOSE RANDOM 129\\n• MAGNESIUM 1.9\\n• Magnesium [Mass/volume] in Serum or Plasma 1.9\\n• POTASSIUM 4.0\\n• Potassium [Moles/volume] in Serum or Plasma 4.0\\n• SODIUM 144\\n• Sodium [Moles/volume] in Serum or Plasma 144\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 56\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 22\\n• Erythrocyte distribution width [Ratio] by Automated count 16.0\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 32.7\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 32.3\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 101.1\\n• Erythrocytes [#/volume] in Blood 3.58\\n• HEMATOCRIT 36.2\\n• Hematocrit [Volume Fraction] of Blood 36.2\\n• HEMOGLOBIN 11.7\\n• Hemoglobin [Mass/volume] in Blood 11.7\\n• Leukocytes [#/volume] in Blood 9.6\\n• MEAN CORPUSCULAR HEMOGLOBIN 32.7\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 32.3\\n• MEAN CORPUSCULAR VOLUME 101.1\\n• MEAN PLATELET VOLUME 11.2\\n• PLATELET COUNT 176\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.2\\n• Platelets [#/volume] in Blood by Automated count 176\\n• RED BLOOD CELL COUNT 3.58\\n• RED CELL DISTRIBUTION WIDTH 16.0\\n• WBC ADJUSTED 9.6"},{"startDate":"2023-08-19T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient ATKESON, BENJAMIN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient WAKE RADIOLOGY CONSULTANTS PA Inpatient - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 21"},{"startDate":"2023-08-18T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• SICK SINUS SYNDROME I49.5  - Specified Heart Arrhythmias(V24,V28)\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• REPEATED FALLS R29.6  - --\\n• ABNORMAL COAGULATION PROFILE R79.1  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-18T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• CREATININE 2.01\\n• Creatinine [Mass/volume] in Serum or Plasma 2.01\\n• EGFR CKD-EPI (2021) MALE 32\\n• Glomerular filtration rate/1.73 sq M.predicted 32\\n• PLATELET COUNT 178\\n• Platelets [#/volume] in Blood by Automated count 178"},{"startDate":"2023-08-18T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient FRENCH, JOHN Inpatient - REX HOSPITAL INC - Claim - 21"},{"startDate":"2023-08-17T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• HYPERLIPIDEMIA, UNSPECIFIED E78.5  - --\\n• ESSENTIAL (PRIMARY) HYPERTENSION I10  - --\\n• OTHER PERICARDIAL EFFUSION (NONINFLAMMATORY) I31.39  - --\\n• OTHER PERICARDIAL EFFUSION (NONINFLAMMATORY) I31.39  - --\\n• OTHER PERICARDIAL EFFUSION (NONINFLAMMATORY) I31.39  - --\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE I50.30  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• CHRONIC KIDNEY DISEASE, UNSPECIFIED N18.9  - --\\n• SHORTNESS OF BREATH R06.02  - --\\n• HYPOXEMIA R09.02  - --\\n• OTHER SPECIFIED ABNORMAL FINDINGS OF BLOOD CHEMISTRY R79.89  - --\\n• OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD R91.8  - --\\n• OTHER INJURY OF UNSPECIFIED BODY REGION, SUBSEQUENT ENCOUNTER T14.8XXD  - --\\n• UNSPECIFIED FALL, SUBSEQUENT ENCOUNTER W19.XXXD  - --\\n• LONG TERM (CURRENT) USE OF ANTITHROMBOTICS/ANTIPLATELETS Z79.02  - --\\n• OTHER LONG TERM (CURRENT) DRUG THERAPY Z79.899  - --\\n• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-08-17T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma >20000.0\\n• PRO-BNP >20000.0\\n• D-DIMER 1245\\n• Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay 1245\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19\\n• ALBUMIN 2.9\\n• Albumin [Mass/volume] in Serum or Plasma 2.9\\n• ALKALINE PHOSPHATASE 47\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 47\\n• ALT (SGPT) 19\\n• ANION GAP 8\\n• Anion gap 3 in Serum or Plasma 8\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 42\\n• AST (SGOT) 42\\n• BILIRUBIN TOTAL 0.4\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.4\\n• BLOOD UREA NITROGEN 33\\n• BUN / CREAT RATIO 16\\n• CALCIUM 8.8\\n• Calcium [Mass/volume] in Serum or Plasma 8.8\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 23.0\\n• CHLORIDE 111\\n• Chloride [Moles/volume] in Serum or Plasma 111\\n• CO2 23.0\\n• CREATININE 2.01\\n• Creatinine [Mass/volume] in Serum or Plasma 2.01\\n• EGFR CKD-EPI (2021) MALE 32\\n• Glomerular filtration rate/1.73 sq M.predicted 32\\n• Glucose [Mass/volume] in Serum or Plasma 89\\n• GLUCOSE RANDOM 89\\n• MAGNESIUM 1.8\\n• Magnesium [Mass/volume] in Serum or Plasma 1.8\\n• POTASSIUM 4.3\\n• Potassium [Moles/volume] in Serum or Plasma 4.3\\n• Protein [Mass/volume] in Serum or Plasma 6.3\\n• PROTEIN TOTAL 6.3\\n• SODIUM 142\\n• Sodium [Moles/volume] in Serum or Plasma 142\\n• THYROID STIMULATING HORMONE 3.524\\n• Thyrotropin [Units/volume] in Serum or Plasma 3.524\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 33\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 16"},{"startDate":"2023-08-17T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 93306 Clinical TTE W/DOPPLER COMPLETE"},{"startDate":"2023-08-17T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient AKHTAR, MATEEN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient ATHUS, ROMAIN Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient CHUGHTAI, SHAHEERA Inpatient - REX HOSPITAL INC - Claim - 21\\n• Inpatient WAKE RADIOLOGY CONSULTANTS PA Inpatient - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 21\\n• Emergency Room WAKE RADIOLOGY CONSULTANTS PA Emergency Room - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 23"},{"startDate":"2023-08-16T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ANEMIA IN CHRONIC KIDNEY DISEASE D63.1  - --\\n• ANEMIA IN OTHER CHRONIC DISEASES CLASSIFIED ELSEWHERE D63.8  - --\\n• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• DEFICIENCY OF OTHER SPECIFIED B GROUP VITAMINS E53.8  - --\\n• MIXED HYPERLIPIDEMIA E78.2  - --\\n• FLUID OVERLOAD, UNSPECIFIED E87.70  - --\\n• FLUID OVERLOAD, UNSPECIFIED E87.70  - --\\n• NICOTINE DEPENDENCE, CIGARETTES, UNCOMPLICATED F17.210  - --\\n• RHEUMATIC DISORDERS OF BOTH AORTIC AND TRICUSPID VALVES I08.2  - --\\n• HYPERTENSIVE HEART DISEASE WITH HEART FAILURE I11.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE WITH HEART FAILURE AND STAGE 1 THROUGH STAGE 4 CHRONIC I13.0  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HYPERTENSIVE URGENCY I16.0  - --\\n• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS I25.10  - --\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE I50.33  - Congestive Heart Failure(V24);Acute on Chronic Heart Failure(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• HEART FAILURE, UNSPECIFIED I50.9  - Congestive Heart Failure(V24);Heart Failure, Except End-Stage and Acute(V28)\\n• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• ORTHOSTATIC HYPOTENSION I95.1  - --\\n• PNEUMONIA, UNSPECIFIED ORGANISM J18.9  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) LOWER RESPIRATORY INFECTION J44.0  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH (ACUTE) EXACERBATION J44.1  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE RESPIRATORY FAILURE WITH HYPOXIA J96.01  - Cardio-Respiratory Failure and Shock(V24,V28)\\n• ACUTE KIDNEY FAILURE, UNSPECIFIED N17.9  - Acute Renal Failure\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• SHORTNESS OF BREATH R06.02  - --\\n• OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD R91.8  - --\\n• UNSPECIFIED INJURY OF THORAX, INITIAL ENCOUNTER S29.9XXA  - --\\n• CONTACT WITH AND (SUSPECTED) EXPOSURE TO COVID-19 Z20.822  - --\\n• CONTACT WITH AND (SUSPECTED) EXPOSURE TO COVID-19 Z20.822  - --\\n• LONG TERM (CURRENT) USE OF ANTIBIOTICS Z79.2  - --\\n• LONG TERM (CURRENT) USE OF OPIATE ANALGESIC Z79.891  - --\\n• OTHER LONG TERM (CURRENT) DRUG THERAPY Z79.899  - --\\n• PRESENCE OF CORONARY ANGIOPLASTY IMPLANT AND GRAFT Z95.5  - --"},{"startDate":"2023-08-16T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 19894.2\\n• PRO-BNP 19894.2\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17\\n• ALBUMIN 2.7\\n• Albumin [Mass/volume] in Serum or Plasma 2.7\\n• ALKALINE PHOSPHATASE 44\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 44\\n• ALT (SGPT) 17\\n• ANION GAP 6\\n• Anion gap 3 in Serum or Plasma 6\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 35\\n• AST (SGOT) 35\\n• BILIRUBIN TOTAL 0.3\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.3\\n• BLOOD UREA NITROGEN 34\\n• BUN / CREAT RATIO 16\\n• CALCIUM 8.6\\n• Calcium [Mass/volume] in Serum or Plasma 8.6\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 24.7\\n• CHLORIDE 114\\n• Chloride [Moles/volume] in Serum or Plasma 114\\n• CO2 24.7\\n• CREATININE 2.12\\n• Creatinine [Mass/volume] in Serum or Plasma 2.12\\n• EGFR CKD-EPI (2021) MALE 30\\n• Glomerular filtration rate/1.73 sq M.predicted 30\\n• Glucose [Mass/volume] in Serum or Plasma 98\\n• GLUCOSE RANDOM 98\\n• POTASSIUM 4.4\\n• Potassium [Moles/volume] in Serum or Plasma 4.4\\n• Protein [Mass/volume] in Serum or Plasma 5.7\\n• PROTEIN TOTAL 5.7\\n• SODIUM 145\\n• Sodium [Moles/volume] in Serum or Plasma 145\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 34\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 16\\n• Basophils [#/volume] in Blood by Automated count 0.0\\n• BASOPHILS ABSOLUTE COUNT 0.0\\n• BASOPHILS RELATIVE PERCENT 0.5\\n• Basophils/100 leukocytes in Blood by Automated count 0.5\\n• Eosinophils [#/volume] in Blood by Automated count 0.0\\n• EOSINOPHILS ABSOLUTE COUNT 0.0\\n• EOSINOPHILS RELATIVE PERCENT 0.4\\n• Eosinophils/100 leukocytes in Blood by Automated count 0.4\\n• Erythrocyte distribution width [Ratio] by Automated count 16.1\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 32.4\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 32.7\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 99.0\\n• Erythrocytes [#/volume] in Blood 3.09\\n• HEMATOCRIT 30.6\\n• Hematocrit [Volume Fraction] of Blood 30.6\\n• HEMOGLOBIN 10.0\\n• Hemoglobin [Mass/volume] in Blood 10.0\\n• Leukocytes [#/volume] in Blood 7.9\\n• Lymphocytes [#/volume] in Blood by Automated count 1.8\\n• LYMPHOCYTES ABSOLUTE COUNT 1.8\\n• LYMPHOCYTES RELATIVE PERCENT 23.0\\n• Lymphocytes/100 leukocytes in Blood by Automated count 23.0\\n• MEAN CORPUSCULAR HEMOGLOBIN 32.4\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 32.7\\n• MEAN CORPUSCULAR VOLUME 99.0\\n• MEAN PLATELET VOLUME 11.3\\n• Monocytes [#/volume] in Blood by Automated count 0.9\\n• MONOCYTES ABSOLUTE COUNT 0.9\\n• MONOCYTES RELATIVE PERCENT 11.9\\n• Monocytes/100 leukocytes in Blood by Automated count 11.9\\n• Neutrophils [#/volume] in Blood by Automated count 5.0\\n• NEUTROPHILS ABSOLUTE COUNT 5.0\\n• NEUTROPHILS RELATIVE PERCENT 63.8\\n• Neutrophils/100 leukocytes in Blood by Automated count 63.8\\n• PLATELET COUNT 159\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 11.3\\n• Platelets [#/volume] in Blood by Automated count 159\\n• RED BLOOD CELL COUNT 3.09\\n• RED CELL DISTRIBUTION WIDTH 16.1\\n• WBC ADJUSTED 7.9\\n• INFLUENZA A NEGATIVE\\n• INFLUENZA B NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• Influenza virus A and B and Respiratory syncytial virus RNA panel - Upper respiratory specimen by Probe and target amplification method NEGATIVE\\n• RSV NEGATIVE\\n• SARS coronavirus 2 RNA NEGATIVE\\n• SARS-COV-2 PCR NEGATIVE"},{"startDate":"2023-08-16T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 0121 Auth MED/SURG-GYN 2 BED"},{"startDate":"2023-08-16T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Inpatient COASTAL PLAINS PATHOLOGY PA Inpatient - COASTAL PLAINS PATHOLOGY PA - Claim - 21\\n• Inpatient JOHNSTON HEALTH SERVICES CORPORATION Inpatient - JOHNSTON HEALTH SERVICES CORPORATION - Claim - 21\\n• Emergency Room WAKE EMERGENCY PHYSICIANS PA Emergency Room - WAKE EMERGENCY PHYSICIANS PA - Claim - 23\\n• Emergency Room WAKE RADIOLOGY CONSULTANTS PA Emergency Room - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 23"},{"startDate":"2023-08-14T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• PERIPHERAL VASCULAR DISEASE, UNSPECIFIED I73.9  - Vascular Disease\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED J90  - --\\n• COUGH, UNSPECIFIED R05.9  - --\\n• OTHER NONSPECIFIC ABNORMAL FINDING OF LUNG FIELD R91.8  - --\\n• UNSPECIFIED OPEN WOUND, LEFT LOWER LEG, INITIAL ENCOUNTER S81.802A  - --"},{"startDate":"2023-08-14T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 72578005518 Doxycycline Hyclate Cap 100 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 14 - Supply: 7"},{"startDate":"2023-08-14T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"• Observation WAKE RADIOLOGY CONSULTANTS PA Observation - WAKE RADIOLOGY CONSULTANTS, PA - Claim - 22\\n•  WRIGHT, MONTA  - UNC PHYSICIANS NETWORK LLC - Claim - 11\\n•    -  - Clinical - "},{"startDate":"2023-08-08T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• NEOPLASM OF UNSPECIFIED BEHAVIOR OF BONE, SOFT TISSUE, AND SKIN D49.2  - --\\n• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• HYPOTHYROIDISM, UNSPECIFIED E03.9  - --\\n• DEFICIENCY OF OTHER SPECIFIED B GROUP VITAMINS E53.8  - --\\n• DEFICIENCY OF OTHER SPECIFIED B GROUP VITAMINS E53.8  - --\\n• MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED F32.9  - --\\n• OTHER CHRONIC PAIN G89.29  - --\\n• HYPERTENSIVE CHRONIC KIDNEY DISEASE WITH STAGE 1 THROUGH STAGE 4 CHRONIC KIDNEY DISEASE, OR UNSPECIF I12.9  - --\\n• CHRONIC OBSTRUCTIVE PULMONARY DISEASE, UNSPECIFIED J44.9  - Chronic Obstructive Pulmonary Disease(V24);Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders(V28)\\n• LOW BACK PAIN, UNSPECIFIED M54.50  - --\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• CHRONIC KIDNEY DISEASE, STAGE 3 N18.32  - Chronic Kidney Disease, Moderate (Stage 3)(V24);Chronic Kidney Disease, Moderate (Stage 3B)(V28)\\n• OTHER SPECIFIED SYMPTOMS AND SIGNS INVOLVING THE CIRCULATORY AND RESPIRATORY SYSTEMS R09.89  - --\\n• OTHER FATIGUE R53.83  - --"},{"startDate":"2023-08-08T05:00:00.000Z","text":"Lab Test(s)","color":"#33B5E5","type":"Lab","icon":"LAB","eventDetails":"• Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 217\\n• VITAMIN B-12 217\\n• Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 14\\n• ALBUMIN 2.9\\n• Albumin [Mass/volume] in Serum or Plasma 2.9\\n• ALKALINE PHOSPHATASE 45\\n• Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 45\\n• ALT (SGPT) 14\\n• ANION GAP 5\\n• Anion gap 3 in Serum or Plasma 5\\n• Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30\\n• AST (SGOT) 30\\n• BILIRUBIN TOTAL 0.3\\n• Bilirubin.total [Mass/volume] in Serum or Plasma 0.3\\n• BLOOD UREA NITROGEN 25\\n• BUN / CREAT RATIO 15\\n• CALCIUM 8.8\\n• Calcium [Mass/volume] in Serum or Plasma 8.8\\n• Carbon dioxide, total [Moles/volume] in Serum or Plasma 25.0\\n• CHLORIDE 114\\n• Chloride [Moles/volume] in Serum or Plasma 114\\n• CO2 25.0\\n• CREATININE 1.62\\n• Creatinine [Mass/volume] in Serum or Plasma 1.62\\n• EGFR CKD-EPI (2021) MALE 42\\n• Glomerular filtration rate/1.73 sq M.predicted 42\\n• Glucose [Mass/volume] in Serum or Plasma 91\\n• GLUCOSE RANDOM 91\\n• POTASSIUM 4.9\\n• Potassium [Moles/volume] in Serum or Plasma 4.9\\n• Protein [Mass/volume] in Serum or Plasma 6.0\\n• PROTEIN TOTAL 6.0\\n• SODIUM 144\\n• Sodium [Moles/volume] in Serum or Plasma 144\\n• Urea nitrogen [Mass/volume] in Serum or Plasma 25\\n• Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma 15\\n• MAGNESIUM 1.9\\n• Magnesium [Mass/volume] in Serum or Plasma 1.9\\n• THYROID STIMULATING HORMONE 2.763\\n• Thyrotropin [Units/volume] in Serum or Plasma 2.763\\n• Erythrocyte distribution width [Ratio] by Automated count 16.1\\n• Erythrocyte mean corpuscular hemoglobin [Entitic mass] by Automated count 33.5\\n• Erythrocyte mean corpuscular hemoglobin concentration [Mass/volume] by Automated count 32.9\\n• Erythrocyte mean corpuscular volume [Entitic volume] by Automated count 101.9\\n• Erythrocytes [#/volume] in Blood 3.45\\n• HEMATOCRIT 35.2\\n• Hematocrit [Volume Fraction] of Blood 35.2\\n• HEMOGLOBIN 11.6\\n• Hemoglobin [Mass/volume] in Blood 11.6\\n• Leukocytes [#/volume] in Blood 6.1\\n• MEAN CORPUSCULAR HEMOGLOBIN 33.5\\n• MEAN CORPUSCULAR HEMOGLOBIN CONC 32.9\\n• MEAN CORPUSCULAR VOLUME 101.9\\n• MEAN PLATELET VOLUME 9.5\\n• PLATELET COUNT 133\\n• Platelet mean volume [Entitic volume] in Blood by Automated count 9.5\\n• Platelets [#/volume] in Blood by Automated count 133\\n• RED BLOOD CELL COUNT 3.45\\n• RED CELL DISTRIBUTION WIDTH 16.1\\n• WBC ADJUSTED 6.1"},{"startDate":"2023-08-08T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 00487020103 Ipratropium-Albuterol Nebu Soln 0.5-2.5(3) MG/3ML Inhalation \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 10"},{"startDate":"2023-08-08T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 94640 Clinical AIRWAY INHALATION TREATMENT\\n• 3078F Clinical DIAST BP <80 MM HG\\n• 3077F Clinical SYST BP >/= 140 MM HG\\n• 96127 Clinical BRIEF EMOTIONAL/BEHAV ASSMT\\n• J7620 Clinical ALBUTEROL IPRATROP NON-COMP"},{"startDate":"2023-08-08T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  REX HEALTHCARE OF WAKEFIELD- LABORATORY  - REX HOSPITAL INC - Claim - 81\\n•  WRIGHT, MONTA  - UNC PHYSICIANS NETWORK LLC - Claim - 11"},{"startDate":"2023-08-06T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 70377000813 Rosuvastatin Calcium Tab 20 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-07-31T05:00:00.000Z","text":"Black Card","color":"#464646","type":"Benefit","icon":"BLACKCARD","eventDetails":"• Benefit Black Card - SMITHFIELD FAMILY DENT - SMITHFIELD -300 "},{"startDate":"2023-07-25T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITH OTHER FORMS OF ANGINA PECTORIS I25.118  - Angina Pectoris\\n• SHORTNESS OF BREATH R06.02  - --"},{"startDate":"2023-07-25T05:00:00.000Z","text":"HCC","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Prostate, Breast, and Other Cancers and Tumors"},{"startDate":"2023-07-25T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• G1004 Clinical CDSM NDSC\\n• J2785 Clinical REGADENOSON INJECTION\\n• 93015 Clinical CARDIOVASCULAR STRESS TEST\\n• A9500 Clinical TC99M SESTAMIBI\\n• 78452 Clinical HT MUSCLE IMAGE SPECT MULT"},{"startDate":"2023-07-25T05:00:00.000Z","text":"Visit(s)","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  AKHTAR, MATEEN  - REX HOSPITAL INC - Claim - 11\\n•    -  - Clinical - "},{"startDate":"2023-07-24T05:00:00.000Z","text":"Diagnosis","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• PRESENCE OF CARDIAC PACEMAKER Z95.0  - --"},{"startDate":"2023-07-24T05:00:00.000Z","text":"Procedure(s)","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 93294 Clinical REM INTERROG EVL PM/LDLS PM\\n• 93296 Clinical REM INTERROG EVL PM/IDS"},{"startDate":"2023-07-24T05:00:00.000Z","text":"Visit","color":"#CDC6FF","type":"Visit","icon":"OBS","eventDetails":"•  SHAH, SIDHARTH  - REX HOSPITAL INC - Claim - 11"},{"startDate":"2023-07-20T05:00:00.000Z","text":"Diagnosis(s)","color":"#FFA500","type":"Diagnosis","icon":"APPROVED","eventDetails":"• ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITH OTHER FORMS OF ANGINA PECTORIS I25.118  - Angina Pectoris\\n• SHORTNESS OF BREATH R06.02  - --"},{"startDate":"2023-07-20T05:00:00.000Z","text":"Procedure","color":"#A9A9A9","type":"Procedure","icon":"PROC","eventDetails":"• 78452 Auth HT MUSCLE IMAGE SPECT MULT"},{"startDate":"2023-07-19T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 68382080701 Trazodone HCl Tab 150 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-07-16T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 16729044915 Levothyroxine Sodium Tab 75 MCG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-07-14T05:00:00.000Z","text":"Medication","color":"#90EE90","type":"Medication","icon":"RX","eventDetails":"• 31722059690 Fenofibrate Tab 145 MG ORAL \\nWALMART PHARMACY 10-1321 - Quantity: 90 - Supply: 90"},{"startDate":"2023-07-12T05:00:00.000Z","text":"HCC","color":"#FFA500","type":"HCC","icon":"TELEDOCTOR","eventDetails":"• Chronic Condition Exudative Macular Degeneration"}]';

module.exports = {
    mock
};